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Iِncreased expression of T- cell- surface CXCR4 in asthmatic children. 
 
INTRODUCTION 
Chemokines are a group of cytokines that are 
responsible for the influx of blood cells, including 
T and B lymphocytes, monocytes, neutrophils, 
eosinophils and basophils in allergic and other 
inflammatory conditions. They function as G-
protein-coupled chemotactic factors which also 
activate the cells with which they interact. Certain 
chemokines function within the afferent arm of the 
immune system, in which antigen is processed and 
antibody formation initiated and others are active 
within the effector pathways of cellular immunity 
and late phase allergic reactions 1. On the basis of 
their sequence of arranged cysteine groups, 
chemokines are categorized into 4 subfamilies: the 
alpha (CXC), beta (CC), gamma (C) and delta 
(CX3C) chemokines 2. 
The interaction between chemokines and their 
receptors is an important step in the control of 
leukocyte migration into sites of inflammation. 
Chemokines also mediate a variety of effects 
independent of chemotaxis, including induction 
and enhancement of Th1 and Th2 associated 
cytokine responses 3. 
One of the typical aspects of airway 
inflammation is the infiltration of Th2 cells and 
differentiation of B cells into IgE secretory plasma 
cells through a complex cascade of events in 
which adhesion molecules and chemokine receptor 
CXCR4 plays a crucial role 4. 
Studies on the properties of peripheral blood 
T-cells in adult asthma have suggested that the 
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properties of these cells reflect those of cells in the 
bronchial mucosa owing perhaps to recirculation 
of the activated T-cells into the peripheral blood 5. 
Owing to this observation, together with the lack 
of data on CXR4 expression in peripheral blood T 
lymphocytes in pediatric asthma we carried out 
this study to verify the possible changes in its level 





This follow up study comprised 25 asthmatic and 
30 healthy children. An informed consent was 
obtained from their parents before enrollment. 
Their demographic data were as follows: 
A) Patients: 
The patients were 25 asthmatic children recruited 
from the Pediatric Allergy and Immunology Unit, 
Children's Hospital, Ain Shams University, Cairo, 
Egypt, during the period from August to October 
2002. The diagnosis of asthma was established 
according to the American Thoracic Society 
(ATS) criteria6. They were 14 males and 11 
females. Their ages ranged from 5 to 12 years with 
a mean value of 7.3 ± 2.4 years.  
The patients were evaluated during acute 
asthmatic attacks and were classified into 10 
children with acute mild, 11 with acute moderate 
and 9 with acute severe asthma. Our patients were 
followed up and re-evaluated in between attacks. 
They were subdivided according to the grading of 
asthma disease into 6 patients with mild 
intermittent asthma, (MI), 9 with mild persistent 
asthma (MP), 6 with moderate persistent asthma 
(OP), and 4 patients with severe persistent asthma 
(SP). The severity of asthma during and in 
between attacks was assessed according to GINA 
guidelines criteria7. 
At the time of initial sampling, 11 children 
were on corticosteroid therapy (inhaled fluticasone 
propionate 100-300 µg/day) together with other 
medications such as β2 agonists and/or theophyllin 
while 14 children were not receiving steroids. 
B) Controls: 
This group comprised 30 healthy children. They 
were 18 males and 12 females. Their ages ranged 
from 4 to 12 years (mean ± SD = 7.4 ± 2.5years). 




Patients were subjected to history taking, 
clinical examination, plain x-ray chest postero-
anterior view, complete blood counting, serum 
total IgE by ELISA and measurement of CXCR4 
by flow cytometry 
Blood Sampling: 
Five ml of venous blood were drawn from each 
patient and divided as follows: 
a- 3 ml dispensed gently into a tube containing 
EDTA as anticoagulant (1.2 mg/m1). This 
anticoagulated blood was used for performing 
both complete blood counting and CXCR4 
analysis. 
b- 2 ml were left to clot. Serum separated and 
collected in sterile clean tubes. Samples were 
preserved at -20˚C until used for IgE assay. 
Flow cytometric analysis: Surface CXCR4 
analysis was done on T-lymphocytes by flow 
cytometry8 using Coulter EPICS XL (Coulter 
electronics, Hielaeh FI, USA) by direct 
immunofluorescence technique. The analysis was 
performed on whole blood, and lysis of red blood 
cells was done by adding 3 ml NH4Cl (0.83% 
buffered with KHCO3, pH 7.2) for 5 minutes at 
37˚C. Optimal dilutions of CXCR4 antibody 
labeled with phycoerythrin (CXCR4-PE) were 
used along with isotype-matched negative 
controls. Lymphocytes were electronically gated 
using light scatter parameters (forward and side 
scatters). The values were expressed in %. A 
sample was considered positive when > 20% of 
the cells showed the marker. The CXCR4 
monoclonal antibody was purchased from R&D 
Systems (Kinley Palace N.E., Minneapolis, MN, 
USA).  
Serum total IgE: Immunoglobulin E was 
measured by ELISA technique  (Medix Biotech 
Inc., Agenzyme Company, San Carios CA, USA). 
The value of IgE used for data analysis was the 
percentage from the highest normal for age9 as 
follows: patient’s actual value/ highest normal 
value for age x100. 
Complete blood counting: This included total 
and differential leucocytic count, band cells, 
absolute eosinophilic and basophilic counts using 
Coulter Counter (Coulter MicroDiff 18, Fullerton 
CA, USA). Children whose absolute eosinophil 
counts exceeded 700 were considered to have 
peripheral blood eosinophilia 9. Blood sampling of 
all subjects was performed at the same time daily 




The results were statistically analyzed via a 
standard computer program (StatView). For non 
parametric data, Mann-Whitney (U) test was used 
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for inter-group analysis, and the Spearman 
correlation coefficient (r) tests were used for intra-




Results of CXCR4 expression 
The percentage of CXCR4 expression on 
peripheral blood  T lymphocytes during acute 
asthmatic attacks ranged from 30% to 99 % 
(median  =  63.7%;  mean ± SD = 62.27 ± 
17.57%). These values were significantly higher 
than the corresponding values of the same patients 
when studied in between the attacks which ranged 
from 19% to 73 % (median = 40%;  mean ± SD = 
40.90 ± 13.25 % ). The healthy children  had 
significantly lower CXCR4 expression (range = 
16-48%; median = 23%;  mean  ± SD = 24.76 ± 
6.88%) as compared to asthmatics both in acute 
attacks and in remission (table 1 and figure 1).  
 
Table (1): Comparison between the studied 
groups in CXCR4 expression on T-cells.  
Groups                                                                      Mean ± SD Z p
Asthmatics in acute 
attacks vs controls     
62.27±17.57 
vs            
24.76±6.88 
6.18         <0.001 
Asthmatics  
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Figure (1): CXCR4 expression in peripheral 
blood T-lymphocytes in the studied groups. 
Horizontal lines indicate the median values and 
boxes enclose the interquartiles. The ranges are 
marked as maximum and minimum . 
Analysis of CXCR4 results of  patient subgroups 
during acute asthmatic attacks 
A significant increase in CXCR4 expression with 
increased severity of the asthmatic attacks was 
observed. The CXCR4 expression was significantly 
higher in children with acute severe asthma as 
compared to those with either acute mild or moderate 
asthma. Also, CXCR4% was significantly higher in 
children with moderate when compared to those with 
mild attacks (table 2).   
 
Table (2): Variation of CXCR4% results with 




































Analysis of CXCR4 results of patient subgroups 
during remission  
Patients with mild intermittent asthma had 
significantly lower CXCR4% when compared to 
any group of persistent asthma. The results of 
CXCR4 expression were comparable between all 
groups of persistent asthma of varying severity 
(table 3). 
 
Table (3): Variation of CXCR4% with grades of 



















































MI = Mild intermittent, MP = Mild persistent, OP = 
Moderate persistent, SP = Severe persistent. 
 
The CXCR4 % was significantly higher in 
patients with eosinophilia in the peripheral blood 
as compared to those having normal eosinophil 
counts during acute asthmatic episodes (mean ± 
SD = 69.55 ± 13.49 vs 43.57 ± 12.34; p<0.001). 
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Also, the CXCR4 levels of asthmatic children 
during acute attacks were positively correlated to 
the absolute eosinophilic counts (AEC) (figure 2).  
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AEC: Absolute eosinophilic count. 
Figure(2):Positive correlation between 
CXCR4% and AEC during acute asthmatic 
attacks. 
 
No significant correlation could be found 
between the CXCR4% and age, duration of illness, 




There is increasing evidence for differential 
expression of various chemokine receptors on 
subsets of Th1 and Th2 cells, which might explain 
their selective migration pattern into inflamed 
tissues. The Th1 cell subset has been shown to 
express CXCR 3 and CCR 5, whereas Th-2 subset 
expresses CCR3, CCR4, CCR8 and CXCR4 
receptors10. Of these, Th-2 cell-expressed 
chemokine receptors, CXCR4, and its ligand SDF-
1, have been shown to be the most relevant for Th-
2-type allergic airway responses 11. 
The results presented demonstrate that 
CXCR4 expression in peripheral blood T 
lymphocytes was significantly increased in 25 
children with acute exacerbation of bronchial 
asthma as compared to controls. After remission 
of acute attacks, the CXCR4 expression decreased 
significantly, however, the levels in between 
attacks were still significantly higher than the 
corresponding values of the control group. The 
persistence of CXCR4 over-expression after 
remission of exacerbations might be due to the 
ongoing process of allergic inflammation in the 
lungs of asthmatics in between attacks as most of 
our patients had persistent rather than intermittent 
asthma. 
We could not trace basal levels of CXCR4 
expression on T cells in children in literature. 
However, our control values (median =23%) go 
with previously published data which revealed that 
only 20% of freshly isolated lymphocytes of 
healthy adults expressed CXCR4 on their cell 
surfaces12. 
Our findings are in accordance with an in vitro 
study in which a single stimulation of peripheral 
blood mononuclear cells with the allergen Der p 
resulted in an enhanced surface expression of 
CXCR4 on about 70% of T cells from atopic 
adults but not in T cells from non atopic donors13.  
Our results emphasize the in-vivo relevance of 
their observations and contrasted the proposal that 
over-expression of CXCR4 in cultured T cells may 
be a culture induced artifact due to relocation of 
intracellular CXCR4 in absence of immunologic 
stimuli14.    
We report a significant increase in CXCR4 
expression with increased severity of the asthmatic 
attacks. This might reflect the excessive 
trafficking and recruitment of lymphocytes at sites 
of inflammation through stimulation of 
CXCR4/SDF-1 axis 15  during acute severe 
asthmatic attacks. 
Patients with mild intermittent asthma had a 
lower expression of CXCR4  when compared to 
persistent asthma, while the results of CXCR4 
expression were comparable between all 
categories of persistent asthma of varying severity. 
This might reflect the ongoing non–stop allergic 
inflammation inside the airways of children with 
persistent asthma as compared to the completely 
reversible changes in those with intermittent 
asthma.  
Our results reflect the importance of CXCR4 
up-regulation in induction of acute severe episodes 
of asthma. This is supported by previously 
published data which showed that IL-4 up-
regulates CXCR4 mRNA expression in CD4+ T 
lymphocytes with the resultant inflammatory cell 
recruitment to sites of inflammation16. The use of 
AMD3100 (a specific inhibitor of CXCR4) was 
found to be associated with a significant reduction 
in IL-4 and IL-5 levels and a significant increase 
in IL –12 and IFNγ  levels within the lungs of 
treated allergic mice with the resultant reduction in 
airway hyperresponsiveness, and overall 
inflammatory response17.  
The relation between eosinophils and 
asthmatic inflammation is extensively studied18. 
Neutralizing antibodies to CXCR4 in a mouse 
model of allergic airway disease reduced lung 
eosinophilia by half, indicating that CXCR4 
El-Gamal et al. 
84 
mediated signals contribute to lung inflammation 
and airway hyper-responsiveness11. Recently, the 
functional expression of CXCR4 in eosinophils 
was reported. SDF-1α was able to induce a strong 
migratory response comparable to the 
CCR3/eotaxin system19. On the other hand, 
Gonzalo and associates11 concluded that the 
observed decrease in eosinophilia after 
neutralization of CXCR4 was likely a secondary 
consequence of reduction of mononuclear cell 
accumulation in the lung owing to their 
observation that eosinophils neither express 
CXCR4 nor respond to SDF-1α. 
In our study, the CXCR4% was significantly 
higher in patients with peripheral blood 
eosinophilia during acute episodes of asthma as 
compared to those without eosinophilia. 
Moreover, a significant positive correlation could 
link the CXCR4% to the absolute eosinophilic 
count during acute asthmatic attacks. 
We could not establish a link between IgE % 
and CXCR4 expression in peripheral blood T 
lymphocytes. This may be explained by the fact 
that a good number of asthmatics have normal 
total IgE levels 9 and therefore, the IgE level is not 
always informative of disease activity although 
closely related to the pathogenesis.   
Taken together, the data presented here 
demonstrate that CXCR4 is over-expressed in T-
lymphocytes of children with bronchial asthma 
and is closely related to disease activity and 
persistence of the disease. The realization that Th-
2 subsets overexpress specific chemokine 
receptors in asthma suggests that targeting the 
correct chemokine receptor may have a significant 
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